Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells
Applied Microbiology and Biotechnology · 2024-12 · 108 (1)
DOI: 10.1007/s00253-024-13008-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 29.01.2024. Verfasst von Shao-Lei Geng und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang, 453…. Hauptthemen laut MEDLINE: Apoptosis, Industry. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Henan Provincial Science and Technology Research Project, Youth and Middle-aged Scientific and Technological Innovation Leading Talents Program of the Corps.
Abstract (Originalsprache)
Mammalian cell lines are frequently used as the preferred host cells for producing recombinant therapeutic proteins (RTPs) having post-translational modified modification similar to those observed in proteins produced by human cells. Nowadays, most RTPs approved for marketing are produced in Chinese hamster ovary (CHO) cells. Recombinant therapeutic antibodies are among the most important and promising RTPs for biomedical applications. One of the issues that occurs during development of RTPs is their degradation, which caused by a variety of factors and reducing quality of RTPs. RTP degradation is especially concerning as they could result in reduced biological functions (antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity) and generate potentially immunogenic species. Therefore, the mechanisms underlying RTP degradation and strategies for avoiding degradation have regained an interest from academia and industry. In this review, we outline recent progress in this field, with a focus on factors that cause degradation during RTP production and the development of strategies for overcoming RTP degradation. Key points • The recombinant therapeutic protein degradation in CHO cell systems is reviewed. • Enzymatic factors and non-enzymatic methods influence recombinant therapeutic protein degradation. • Reducing the degradation can improve the quality of recombinant therapeutic proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang, 453003, Henan, China.
- School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, 453003, Henan, China.
- Henan Engineering Research Center for Biopharmaceutical Innovation, Xinxiang Medical University, Xinxiang, 453003, Henan, China.
- School of Pharmacy, Xinxiang Medical University, Xinxiang, 453003, Henan, China.
- International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang, 453003, Henan, China. wtianyuncn@126.com.
- School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, 453003, Henan, China. wtianyuncn@126.com.
Förderung
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Research Project
- Youth and Middle-aged Scientific and Technological Innovation Leading Talents Program of the Corps
- Natural Science Foundation of Henan Province
Zitieren
APA
Geng, S. L., Zhao, X. J., Zhang, X., Zhang, J. H., Mi, C. L., & Wang, T. Y. (2024). Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells. Applied Microbiology and Biotechnology, 108(1). https://doi.org/10.1007/s00253-024-13008-6
Vancouver
Geng SL, Zhao XJ, Zhang X, Zhang JH, Mi CL, Wang TY. Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells. Applied Microbiology and Biotechnology. 2024;108(1). doi:10.1007/s00253-024-13008-6
BibTeX
@article{Geng2024,
author = {Geng, Shao-Lei and Zhao, Xiao-Jie and Zhang, Xi and Zhang, Ji-Hong and Mi, Chun-Liu and Wang, Tian-Yun},
title = {Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells},
journal = {Applied Microbiology and Biotechnology},
year = {2024},
volume = {108},
number = {1},
doi = {10.1007/s00253-024-13008-6}
}
EUVIMED